EditorialEditorials
A New Era for Ribavirin Aerosols to Treat Respiratory Syncitial Virus Infections in Immunocompromised Patients?
Patrice Diot and Laurent Plantier
Respiratory Care May 2016, 61 (5) 714-715; DOI: https://doi.org/10.4187/respcare.04797
Patrice Diot
Université François Rabelais
CEPR / INSERM UMR1100
Department of Pulmonology
CHU de Tours
Tours, France
MD PhDLaurent Plantier
Université François Rabelais
CEPR / INSERM UMR1100
Department of Pulmonology
CHU de Tours
Tours, France
MD PhDReferences
- 1.↵
- Portnoy J,
- Nadel G,
- Amado M,
- Willsie-Ediger S
- 2.↵
- 3.↵
- Shah DP,
- Ghantoji SS,
- Shah JN,
- El Taoum KK,
- Jiang Y,
- Popat U,
- et al
- 4.
- Chemaly RF,
- Shah DP,
- Boeckh MJ
- 5.↵
- Seo S,
- Campbell AP,
- Xie H,
- Chien JW,
- Leisenring WM,
- Englund JA,
- Boeckh M
- 6.↵
- Chemaly RF,
- Torres HA,
- Munsell MF,
- Shah DP,
- Rathod DB,
- Bodey GP,
- et al
- 7.↵
- Fätkenheuer G,
- Gillor D,
- Platten M,
- Kochanek M,
- Salzberger B
- 8.↵
- Walsh BK,
- Betit P,
- Fink JB,
- Pereira LM,
- Arnold J
- 9.↵
- 10.↵
- 11.↵
- 12.↵
- Iacono AT,
- Johnson BA,
- Grgurich WF,
- Youssef JG,
- Corcoran TE,
- Seiler DA,
- et al
In this issue
Respiratory Care
Vol. 61, Issue 5
1 May 2016
A New Era for Ribavirin Aerosols to Treat Respiratory Syncitial Virus Infections in Immunocompromised Patients?
Patrice Diot, Laurent Plantier
Respiratory Care May 2016, 61 (5) 714-715; DOI: 10.4187/respcare.04797